Europe Neurostimulation Devices Market

Historic Data: 2020-2021   |   Base Year: 2022   |   Forecast Period: 2023-2030

Analysis - by Product (Spinal Cord Stimulator, Deep Brain Stimulator, Sacral Nerve Stimulator, Vagus Nerve Stimulator, and Others), Application (Pain Management, Epilepsy, Urinary and Fecal Incontinence, Parkinson\'s Disease, and Others), and End User (Hospitals, Specialty Clinics, and Others)


No. of Pages: 91    |    Report Code: BMIRE00030035    |    Category: Life Sciences

Europe Neurostimulation Devices Market
Buy Now
The Europe neurostimulation devices market was valued at US$ 1,717.84 million in 2022 and is expected to reach US$ 3,459.24 million by 2030; it is estimated to register a CAGR of 9.1% from 2022 to 2030.

Rising Cases of Spinal Cord Injury Fuel Europe Neurostimulation Devices Market

The neurostimulation devices industry has gained traction owing to the rising elderly population prone to various spinal disorders. These population is becoming more susceptible to developing spinal disorders such as degenerative disc diseases, osteoarthritis, scoliosis, spinal tumor, and spinal stenosis. As this population ages, the natural wear and tear of the spine can lead to several spinal disorders. Hence, with this fact, the aging population poses a unique challenge to spine surgeons due to multiple increased frailty, medical comorbidities, decreased nutritional status, and the higher probability of postoperative complications. According to the World Health Organization (WHO) data published in October 2022, approximately 80% of the elderly population will be living in low-and middle-income countries by 2050, and it is anticipated that the pace of this population aging will be much faster than in the past. The aging demographic, coupled with lifestyle-related factors has led to a substantial increase in individuals experiencing spinal issues such as degenerative disc disease and spinal deformities. Therefore, high incidence of spinal cord injuries in old age and adults stimulates the demand for neurostimulation devices.

Europe Neurostimulation Devices Market Overview

The Europe neurostimulation devices market is segmented into the UK, Germany, France, Italy, Spain, and the Rest of Europe. The regional market is expected to grow significantly in the coming years owing to the rising prevalence of neurologic disorders such as cerebral aneurysms, stroke, and others and increasing product innovations made by the market players operating in the region. The market growth is also attributed to the development of healthcare systems in countries such as Germany, France, and Spain and rise in innovative product launches by key regional companies. In June 2020, Medtronic announced the launch of the PerceptTM PC Neurostimulator with BrainsenseTM technology. The technology simultaneously records and delivers electrical stimulations to the brain to relieve symptoms of Parkinson's disease (PD).

Europe Neurostimulation Devices Market Revenue and Forecast to 2030 (US$ Million)

Europe Neurostimulation Devices Market Segmentation

The Europe neurostimulation devices market is segmented based on product, application, end user, and country.

Based on product, the Europe neurostimulation devices market is segmented into spinal cord stimulator, deep brain stimulator, sacral nerve stimulator, vagus nerve stimulator, and others. The spinal cord stimulator segment held the largest market share in 2022.

In terms of application, the Europe neurostimulation devices market is categorized into pain management, epilepsy, urinary and fecal incontinence, Parkinson's disease, and others. The pain management segment held the largest market share in 2022.

By end user, the Europe neurostimulation devices market is segmented into hospitals, specialty clinics, and others. The hospitals segment held the largest market share in 2022.

Based on country, the Europe neurostimulation devices market is segmented into the UK, Germany, France, Italy, Spain, and the Rest of Europe. Germany dominated the Europe neurostimulation devices market share in 2022.

Medtronic Plc, Boston Scientific Corp, Abbott Laboratories, Nevro Corp, LivaNova Plc, Synapse Biomedical Inc, ElectroCore Inc, and Mainstay Medical are some of the leading companies operating in the Europe neurostimulation devices market.

Europe Neurostimulation Devices Strategic Insights

Strategic insights for the Europe Neurostimulation Devices provides data-driven analysis of the industry landscape, including current trends, key players, and regional nuances. These insights offer actionable recommendations, enabling readers to differentiate themselves from competitors by identifying untapped segments or developing unique value propositions. Leveraging data analytics, these insights help industry players anticipate the market shifts, whether investors, manufacturers, or other stakeholders. A future-oriented perspective is essential, helping stakeholders anticipate market shifts and position themselves for long-term success in this dynamic region. Ultimately, effective strategic insights empower readers to make informed decisions that drive profitability and achieve their business objectives within the market.

strategic-framework/europe-neurostimulation-devices-market-strategic-framework.webp
Get more information on this report

Europe Neurostimulation Devices Report Scope

Report Attribute Details
Market size in 2022 US$ 1,717.84 Million
Market Size by 2030 US$ 3,459.24 Million
Global CAGR (2022 - 2030) 9.1%
Historical Data 2020-2021
Forecast period 2023-2030
Segments Covered By Product
  • Spinal Cord Stimulator
  • Deep Brain Stimulator
  • Sacral Nerve Stimulator
  • Vagus Nerve Stimulator
By Application
  • Pain Management
  • Epilepsy
  • Urinary and Fecal Incontinence
  • Parkinson's Disease
By End User
  • Hospitals
  • Specialty Clinics
Regions and Countries Covered Europe
  • UK
  • Germany
  • France
  • Russia
  • Italy
  • Rest of Europe
Market leaders and key company profiles
  • Medtronic Plc
  • Boston Scientific Corp
  • Abbott Laboratories
  • Nevro Corp
  • LivaNova Plc
  • Synapse Biomedical Inc
  • ElectroCore Inc
  • Mainstay Medical
  • Get more information on this report

    Europe Neurostimulation Devices Regional Insights

    The geographic scope of the Europe Neurostimulation Devices refers to the specific areas in which a business operates and competes. Understanding local distinctions, such as diverse consumer preferences (e.g., demand for specific plug types or battery backup durations), varying economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved areas or adapting their offerings to meet local demands. A clear market focus allows for more effective resource allocation, targeted marketing campaigns, and better positioning against local competitors, ultimately driving growth in those targeted areas.

    geography/europe-neurostimulation-devices-market-geography.webp
    Get more information on this report

    The List of Companies - Europe Neurostimulation Devices Market

    1. Medtronic Plc

    2. Boston Scientific Corp

    3. Abbott Laboratories

    4. Nevro Corp

    5. LivaNova Plc

    6. Synapse Biomedical Inc

    7. ElectroCore Inc

    8. Mainstay Medical

    Frequently Asked Questions
    How big is the Europe Neurostimulation Devices Market?

    The Europe Neurostimulation Devices Market is valued at US$ 1,717.84 Million in 2022, it is projected to reach US$ 3,459.24 Million by 2030.

    What is the CAGR for Europe Neurostimulation Devices Market by (2022 - 2030)?

    As per our report Europe Neurostimulation Devices Market, the market size is valued at US$ 1,717.84 Million in 2022, projecting it to reach US$ 3,459.24 Million by 2030. This translates to a CAGR of approximately 9.1% during the forecast period.

    What segments are covered in this report?

    The Europe Neurostimulation Devices Market report typically cover these key segments-

    • Product (Spinal Cord Stimulator, Deep Brain Stimulator, Sacral Nerve Stimulator, Vagus Nerve Stimulator)
    • Application (Pain Management, Epilepsy, Urinary and Fecal Incontinence, Parkinson\'s Disease)
    • End User (Hospitals, Specialty Clinics)

    What is the historic period, base year, and forecast period taken for Europe Neurostimulation Devices Market?

    The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Europe Neurostimulation Devices Market report:

  • Historic Period : 2020-2021
  • Base Year : 2022
  • Forecast Period : 2023-2030
  • Who are the major players in Europe Neurostimulation Devices Market?

    The Europe Neurostimulation Devices Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:

  • Medtronic Plc
  • Boston Scientific Corp
  • Abbott Laboratories
  • Nevro Corp
  • LivaNova Plc
  • Synapse Biomedical Inc
  • ElectroCore Inc
  • Mainstay Medical
  • Who should buy this report?

    The Europe Neurostimulation Devices Market report is valuable for diverse stakeholders, including:

    • Investors: Provides insights for investment decisions pertaining to market growth, companies, or industry insights. Helps assess market attractiveness and potential returns.
    • Industry Players: Offers competitive intelligence, market sizing, and trend analysis to inform strategic planning, product development, and sales strategies.
    • Suppliers and Manufacturers: Helps understand market demand for components, materials, and services related to concerned industry.
    • Researchers and Consultants: Provides data and analysis for academic research, consulting projects, and market studies.
    • Financial Institutions: Helps assess risks and opportunities associated with financing or investing in the concerned market.

    Essentially, anyone involved in or considering involvement in the Europe Neurostimulation Devices Market value chain can benefit from the information contained in a comprehensive market report.

    Available Report Formats

    pdf-format excel-format pptx-format
    Buy Now